Moderna Inc.MRNA
Close of Friday, October 23, 2026 · Moderna Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$200.10
vs its Pivot
+143.5%
OnlyAlpha Score
49
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +2.7% | +578.6% | +645.3% | +32.5% | -9.2% |
No dividend in the last 12 months.
Who runs and owns it
Run by Stephane Bancel (CEO), one of the Forbes billionaires.
In these funds
Suppliers, customers and partners
Partners and deals
| Merck & Co. | intismeran (mRNA-4157) |
| Vertex Pharmaceuticals | CF candidate mRNA-3692/VX-522 |
| Recordati (Italy) | strategic collaboration |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get MRNA in your free daily emailAfter every close: whether MRNA is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track MRNA free → Full Stock check
Track MRNA free → Full Stock check